CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 60 enrolled
Drug / intervention
Cultured human intestinal microbiota +2 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02857582
NCT02857582Phase 2Completed

Transplantation of Cultured Gut Microflora to Repeat Antibiotic-induced Diarrhea Due to Clostridium Difficile

Per Hellström·interventional·Posted Aug 5, 2016·Updated Jan 9, 2019

In Brief

A Phase 2 clinical trial evaluating Cultured human intestinal microbiota, Vancomycin, and 1 other intervention for Clostridium Difficile. Completed, enrolled 60 participants across 1 site.

Detailed Summary

Patients who have received antibiotics and thereafter developed diarrhea are investigated for presence of Clostridium difficile toxin. Primary treatment is given with oral metronidazole/vancomycin. In case of relapse, secondary treatment is given with either cultured gut microbiota rectally or oral vancomycin in sequence. In those cases where secondary treatment with vancomycin fails cultured gut microbiota is given as final treatment. As an extension treatment, all failures were treated with cluttered gut microbiota through the upper route. In both cases As an alternative cultured gut microbiota may be given via the duodenal route. Follow-up is carried out after 7, 30 and 90 days with interview and stool collection for analysis of Clostridium difficile.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSweden

Timeline

Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 5, 2016
Enrollment StartOct 1, 2014
Primary CompletionOct 1, 2018
Study CompletionDec 1, 2018
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 9.9 years ago

Interventions

Cultured human intestinal microbiotabiological

Secondary treatment for C diff in replacement for regular vancomycin.

Vancomycindrug

Active comparator to treatment with ACHIM

Metronidazoledrug

Primary treatment for C diff in all treatment arms